| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | €25.7M | −8.2% |
| Gross Profit | — | — |
| EBITDA | -€1.6M | — |
| Net Income | -€13.4M | — |
| Diluted EPS | -€0.05 | — |
| Free Cash Flow | — | — |
| Ratio | 2023 | 2024 | Trend · 2y | vs own |
|---|---|---|---|---|
| ▾Margins | ||||
| Operating Margin | −60.71% | −68.09% | 25% | |
| EBITDA Margin | −18.21% | −6.23% | 75% | |
| NOPAT Margin | −47.96% | −53.79% | 25% | |
| Net Margin | −28.57% | −52.14% | 25% | |
| OCF Margin | 55.36% | −24.51% | 25% | |
| ▸Returns on Capital · 4 ratios | ||||
| ▸DuPont factors (ROE drivers) · 2 ratios | ||||
| ▸Earnings quality · 2 ratios | ||||
| ▸Liquidity & coverage · 5 ratios | ||||
| ▸Leverage · 8 ratios | ||||
| ▸Working capital · 3 ratios | ||||
| Line | 2023 | 2024 |
|---|---|---|
| Revenue | €28.0M | €25.7M |
| YoY % | -8.2% | |
| Total Operating Expenses | €12.6M | €12.5M |
| YoY % | -0.8% | |
| Operating Income | -€17.0M | -€17.5M |
| Interest Expense | €8.4M | €7.1M |
| YoY % | -15.5% | |
| Interest & Investment Income | €6.3M | €5.3M |
| YoY % | -15.9% | |
| Equity Method Income | -€2.7M | -€6.0M |
| Pretax Income | -€19.1M | -€19.3M |
| Income Tax | -€11.5M | -€6.0M |
| Net Income (incl. NCI) | -€7.6M | -€13.3M |
| Minority Interest (P&L) | €400,000 | €100,000 |
| YoY % | -75.0% | |
| Net Income | -€8.0M | -€13.4M |
| EPS (Basic) | -€0.03 | -€0.05 |
| EPS (Diluted) | -€0.03 | -€0.05 |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
